CVS Health stock

CVS · NYSE · USD

Compare CVS Health
$85.81Change from previous close: −3.14%Absolute change: −$2.78

Close · November 17, 2026

Price history

+10.00% over the period

1 year: from $78.41 (November 17, 2025) to $86.25 (November 17, 2026), +10.00%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 17, 2026$86.25
October 30, 2026$90.25
September 30, 2026$85.69
August 31, 2026$93.91
July 31, 2026$104.43
June 30, 2026$103.45
May 29, 2026$90.98
April 30, 2026$83.29
March 31, 2026$71.82
February 27, 2026$79.90
January 30, 2026$74.52
December 31, 2025$79.36
November 28, 2025$80.36
November 17, 2025$78.41

At a glance

  • The company

    Operates a health care ecosystem encompassing health insurance, pharmacy benefit management, and retail pharmacy services

  • Latest results

    Quarter to September 30, 2026 · EPS $2.09 (estimate $1.65)

TickerLandia's take on CVS Health

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$69.51
52-wk high$110.68

−22.47% from the 52-week high

Analysts · 28 analysts

Average target$109.31+27.38% vs. price

Buy 25 · Hold 3 · Sell 0 · Strong buy

TickerLandia Fingerprint: CVS Health

Compared with similar companies: very low price.

Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

CVS Health is pricier than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2025), CVS Health's P/E today is 62.1, above the median of its last 9 fiscal years (14.6; between 11.3 and 57.1 from 2016 to 2025). CVS Health's P/E (trailing 12 months): 10.4, −45% against the median of a group of 7 similar companies (18.9).

P/E compared with its history

Compared with 7 similar companies

CVS Health's metrics compared with similar companies
MetricCVS HealthPosition in the groupBand
P/E (trailing 12 months)10.4Low
Forward P/E10.2Middle
Operating margin3.1%Middle
ROE14.4%Middle
Debt/equity0.93High

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: CVS Health. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$107.75B

Latest quarter · Q3 2026

Net income

$2.17B

Latest quarter · Q3 2026

Quarterly net margin

2.0%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
$113.35B
P/E
10.4
EPS
$8.54
Volume
11.36M
Daily trading
€924.06M
Dividend yield
3.10%
Last ex-dividend on October 22, 2026

How CVS Health is changing

All results
  • Revenue grew 8.4% a year on average over the last 5 years

  • Operating margin fell from 2.5% to 1.2%

  • Profits turn into cash: free cash flow equal to 167% of net income

Returns

CVS Health returns with dividends

$1,000 invested in CVS Health 5 years ago, on November 17, 2021, would be worth $1,099 today with dividends reinvested: +9.85% in total, +1.90% per year. On price alone it would be $930 (−6.99%).

PeriodCVS HealthS&P 500$1,000 becomes
1 month−6.94%−3.17%$931
6 months−10.51%+0.11%$895
Year to date+8.68%+8.34%$1,087
1 year+13.31%+11.15%$1,133
3 years+40.23%+64.30%$1,402
5 years+9.85%+58.18%$1,099
10 years+58.36%+239.10%$1,584

Over the last 6 months it has done better than 12% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment

The chart in detail

CVS Health: technical analysis

CVS Health shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 24.4% below its highest close since January 2, 1990 ($113.45, July 29, 2015).

Trend
No clear trend
RSI (14 sessions)
44
Between 30 and 70
vs 200-session average
−3.90%

Active signals

  • Death cross: the 50-session average has crossed below the 200-session average.

  • The last session opened more than 3% below the previous close.

Support and resistance

Price areas where CVS Health has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$98.15+14.38%3 touches, last on September 2, 2026
  2. Resistance$92.68+8.01%2 touches, last on August 21, 2026
  3. Resistance$89.72+4.56%2 touches, last on September 28, 2026
  4. Last price$85.81
  5. Support$84.12−1.98%2 touches, last on October 1, 2026
  6. Support$80.82−5.82%6 touches, last on April 9, 2026
  7. Support$77.13−10.12%4 touches, last on November 4, 2026

Volatility and risk

Over the last year it has moved little with the S&P 500.

Beta (1 year) vs S&P 500
−0.02
Volatility (60 sessions, annualised)
38.8%
Largest fall in the last year
−27.70%

Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

CVS Health: seasonality

Average monthly price change over 37 years

+0.2%Jan+1.5%Feb+2.2%Mar+1.6%Apr+0.7%May−0.4%Jun+0.8%Jul−0.8%Aug+0.4%Sep−1.1%Oct+2.9%Nov+1.2%Dec

Over the last 37 years, the strongest month for CVS Health has been November: +2.89% on average, positive in 22 years out of 36. The weakest has been October: −1.14% on average, positive in 17 years out of 37.

Show chart data
MonthAverageMedianPositive years
January+0.16%−0.43%16 of 36
February+1.52%+2.05%22 of 37
March+2.18%+1.94%21 of 37
April+1.63%+0.79%20 of 37
May+0.71%+0.64%19 of 37
June−0.39%−0.53%17 of 37
July+0.83%+0.72%19 of 37
August−0.80%+0.27%19 of 37
September+0.40%−1.77%17 of 37
October−1.14%−1.16%17 of 37
November+2.89%+3.64%22 of 36
December+1.22%+0.54%19 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

CVS Health and its competitors

With 219,000 employees, CVS Health Corporation combines health insurance, pharmacy benefit management and retail pharmacy in the United States. Its health insurance arm offers medical, pharmacy, dental and behavioral health plans, along with Medicare Advantage, Medicare Supplement and prescription drug plans and Medicaid management services, to employers, individuals, students, governments and labor groups. The pharmacy benefit management unit serves employers, insurers, unions and Medicaid managed care plans with formulary management, specialty and mail-order pharmacy, and disease management.

Headquarters
Woonsocket, United States
Employees
219,000
Founded
1963
Chief executive
J. Joyner
CVS Health and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
CVS HealthCVS$113.35B3.1%10.4−10.51%
Elevance HealthELV$96.04B4.0%18.9+10.50%
Cigna GroupCI$77.95B3.9%12.2+3.08%
HumanaHUM$50.12B2.3%39.0+45.30%
UnitedHealth GroupUNH$369.18B5.9%23.5−1.06%
CenteneCNC$33.52B1.9%22.8+24.51%

Same industry or related industries, similar size. Compare CVS Health with its competitors · Full profile